4- ((3- methyl- 6- (benzoxazole- 2- yl)- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene))- 1- (3- trimethylammoniumpropyl)quinolinium

a intercalating ligand; structure in first source

Also Known As:

4-((3-methyl-6-(benzoxazole-2-yl)-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene))-1-(3-trimethylammoniumpropyl)quinolinium dibromide; BOXTO-PRO

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Rupture 02/08/2007 - "A combination of electron microscopy, light scattering, and linear dichroism show that the phages are intact after YO-PRO binding, whereas a small degree of capsid rupture cannot be excluded with BOXTO-PRO."